The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome
- PMID: 17919323
- PMCID: PMC2094702
- DOI: 10.1186/1475-2840-6-29
The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome
Abstract
Background: Women with PCOS have been reported to be at increased risk of a number of gynaecological neoplasias, including endometrial, breast, and ovarian cancer. Studies of the possible association of genetic variation in progesterone receptor polymorphism with risk of ovarian and breast cancer have concentrated on a variant known as PROGINS.
Methods: Ninety-five young women with PCOS and 99 healthy control women were included in our study. All subjects underwent venous blood drawing for complete hormonal assays, lipid profile, glucose, insulin and PROGINS polymorphism genetic study.
Results: In PROGINS polymorphism results; in both control and the patient groups T1/T1 has been detected in high levels. But for genotype (p = 0.178) and allele (p = 0.555) frequencies both of the groups give similar results. Statistically significant difference has been detected on serum FSH levels for T1/T1 genotype according to T2/T2 genotype.
Conclusion: No relation has been detected between the inflammatory and oxidative stress factors, and PROGINS polymorphism alleles. This may be because the PCOS patients are young and their BMI means are normal and their CIMT and oxidative stress markers are like healthy women.
Figures
Similar articles
-
Molecular determination of progesterone receptor's PROGINS allele (Alu insertion) and its association with the predisposition and susceptibility to polycystic ovary syndrome (PCOS).Mamm Genome. 2022 Sep;33(3):508-516. doi: 10.1007/s00335-021-09941-w. Epub 2022 Jan 8. Mamm Genome. 2022. PMID: 34997844
-
Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development.Int J Gynecol Cancer. 2007 Jan-Feb;17(1):229-32. doi: 10.1111/j.1525-1438.2006.00767.x. Int J Gynecol Cancer. 2007. PMID: 17291258
-
Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.Steroids. 2008 Jul;73(6):676-80. doi: 10.1016/j.steroids.2008.02.005. Epub 2008 Feb 23. Steroids. 2008. PMID: 18384825
-
The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage.J Soc Gynecol Investig. 2001 Sep-Oct;8(5):295-8. doi: 10.1016/s1071-5576(01)00123-x. J Soc Gynecol Investig. 2001. PMID: 11677150
-
Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.Clin Endocrinol (Oxf). 2005 Feb;62(2):126-31. doi: 10.1111/j.1365-2265.2004.02183.x. Clin Endocrinol (Oxf). 2005. PMID: 15670186
Cited by
-
Effect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystıc ovary syndrome.Lipids Health Dis. 2011 Oct 28;10:193. doi: 10.1186/1476-511X-10-193. Lipids Health Dis. 2011. PMID: 22035022 Free PMC article.
-
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.Fertil Steril. 2011 Mar 1;95(3):1048-58.e1-2. doi: 10.1016/j.fertnstert.2010.11.036. Epub 2010 Dec 17. Fertil Steril. 2011. PMID: 21168133 Free PMC article.
-
Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey.J Assist Reprod Genet. 2009 Jan;26(1):1-6. doi: 10.1007/s10815-008-9280-8. Epub 2008 Dec 5. J Assist Reprod Genet. 2009. PMID: 19057990 Free PMC article.
References
-
- Spritzer PM, Morsch DM, Wiltgen D. Polycystic ovary syndrome associated neoplasms. Arq Bras Endocrinol Metabol. 2005;49:805–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials